Daniel Washburn, M.D.
Ophthalmology Physician in El Paso, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,090 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daniel Washburn, M.D. reported a CMS MIPS final score of 88.6/100 - above the 83.1 national average - and filed 2,135 Medicare Part D claims in 2023.
- 88.6/100
- MIPS score · +6 vs avg
- 2K
- Part D claims, 2023
- 46%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Washburn, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
89 Top 44% higher than 56% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Washburn, M.D. sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Washburn, M.D. writes more Part D claims than 74% of them and scores higher on MIPS quality than 53% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Daniel Washburn, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Daniel Washburn, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Washburn, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Ophthalmology Physician compares to other specialties among Texas providers
Ophthalmology Physician ranks #51 among Texas's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Daniel Washburn, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 88.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 88.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
88.6/100 MIPS final score - 5.5 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 77.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Washburn, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 8815 DYER ST STE 130, El Paso, TX, 79904, with a listed phone of (915) 757-3937. NPI 1003965096 was issued on 01/09/2007.
Medicare Part D records for calendar year 2023 show 2,135 prescription claims written by this provider, covering 578 Medicare beneficiaries and totaling roughly $444K in drug spend, split 54% brand-name and 46% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.6/100 for the 2023 performance year (Quality 77.2), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003965096 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/09/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Daniel Washburn, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1003965096 is the unique 10-digit identifier CMS uses to link Washburn across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Washburn, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$109
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Daniel Washburn, M.D.. To verify Daniel Washburn, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
54% brand-name claims vs 46% generic, on 2,135 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,307
- Total Day Supply
- 124,458
- Brand vs Generic
- 54% brand / 46% generic
- Brand Drug Cost
- $391K
- Generic Drug Cost
- $53K
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 1.79
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 51, 65-74: 236, 75-84: 212, 85+: 79
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Washburn, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
816 claims
- Lumigan 195
Lumigan
195 claims
- Olopatadine Hcl 154
Olopatadine Hcl
154 claims
- Brimonidine Tartrate 128
Brimonidine Tartrate
128 claims
- Timolol Maleate 119
Timolol Maleate
119 claims
- Brimonidine Tartra… 113
Brimonidine Tartrate-Timolol
113 claims
- Combigan 100
Combigan
100 claims
- Prednisolone Acetate 95
Prednisolone Acetate
95 claims
| Drug | Claims |
|---|---|
| Latanoprost | 816 |
| Lumigan Bimatoprost | 195 |
| Olopatadine Hcl | 154 |
| Brimonidine Tartrate | 128 |
| Timolol Maleate | 119 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 113 |
| Combigan Brimonidine Tartrate/Timolol | 100 |
| Prednisolone Acetate | 95 |
| Dorzolamide Hcl | 91 |
| Simbrinza Brinzolamide/Brimonidine Tart | 78 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Daniel Washburn, M.D. fits within the Ophthalmology Physician landscape nationally.
Daniel Washburn, M.D.'s 2,135 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Washburn.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Daniel Washburn, M.D.'s specialty? ▼
How much does Daniel Washburn, M.D. prescribe under Medicare Part D? ▼
What is Daniel Washburn, M.D.'s Medicare quality score? ▼
Where is Daniel Washburn, M.D. located? ▼
What is Daniel Washburn, M.D.'s NPI number? ▼
Does Daniel Washburn, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Daniel Washburn, M.D. prescribe most often? ▼
Does Daniel Washburn, M.D. accept Medicare? ▼
How can I verify Daniel Washburn, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology